Savara Inc. (SVRA)
 NASDAQ: SVRA · Real-Time Price · USD
 4.300
 -0.040 (-0.92%)
  Oct 30, 2025, 4:00 PM EDT - Market closed
Savara Market Cap
Savara has a market cap or net worth of $905.97 million as of October 30, 2025. Its market cap has increased by 50.39% in one year.
Market Cap 
 905.97M
Enterprise Value 
 788.83M
1-Year Change 
 50.39%
Ranking 
 Category 
 Stock Price 
$4.30
Market Cap Chart
Since April 28, 2017, Savara's market cap has increased from $132.70M to $905.97M, an increase of 582.72%. That is a compound annual growth rate of 25.32%.
Market Cap History
| Date | Market Cap | % Change | 
|---|---|---|
| Oct 29, 2025 | 750.10M | 42.36% | 
| Dec 31, 2024 | 526.90M | -17.17% | 
| Dec 29, 2023 | 636.10M | 259.79% | 
| Dec 30, 2022 | 176.80M | 25.21% | 
| Dec 31, 2021 | 141.20M | 126.65% | 
| Dec 31, 2020 | 62.30M | -66.25% | 
| Dec 31, 2019 | 184.60M | -30.58% | 
| Dec 31, 2018 | 265.90M | -41.25% | 
| Dec 29, 2017 | 452.60M | 241.07% | 
| Apr 28, 2017 | 132.70M | - | 
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
 Full DefinitionRelated Stocks
| Company | Market Cap | 
|---|---|
| Eli Lilly and Company | 735.95B | 
| Johnson & Johnson | 447.26B | 
| AbbVie | 400.48B | 
| UnitedHealth Group | 326.07B | 
| AstraZeneca | 255.54B | 
| Novartis AG | 239.27B | 
| Novo Nordisk | 229.86B | 
| Merck & Co. | 217.48B |